Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and xanomeline

3,4-dihydroxyphenylacetic acid has been researched along with xanomeline in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bymaster, FP; Calligaro, DO; Mitch, CH; Olesen, PH; Sauerberg, P; Schoepp, DD; Shannon, HE; Sheardown, MJ; Suzdak, PD; Swedberg, MD; Ward, JS; Wong, DT	1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and xanomeline

Article	Year
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232). The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Acetylcholinesterase; Administration, Oral; Animals; Biological Availability; Brain; Choline; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Corpus Striatum; Male; Neurotransmitter Agents; Neurotransmitter Uptake Inhibitors; Parasympathomimetics; Psychotropic Drugs; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Salivation; Thiadiazoles	1994

Article

Year

Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).

The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1

Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Acetylcholinesterase; Administration, Oral; Animals; Biological Availability; Brain; Choline; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Corpus Striatum; Male; Neurotransmitter Agents; Neurotransmitter Uptake Inhibitors; Parasympathomimetics; Psychotropic Drugs; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Salivation; Thiadiazoles

1994